Haemonetics - 33 Year Stock Price History | HAE
Historical daily share price chart and data for Haemonetics since 1991 adjusted for splits and dividends. The latest closing stock price for Haemonetics as of November 19, 2024 is 84.83.
- The all-time high Haemonetics stock closing price was 139.48 on February 08, 2021.
- The Haemonetics 52-week high stock price is 97.97, which is 15.5% above the current share price.
- The Haemonetics 52-week low stock price is 70.25, which is 17.2% below the current share price.
- The average Haemonetics stock price for the last 52 weeks is 82.19.
| Haemonetics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 81.8710 | 85.1400 | 97.3700 | 71.1600 | 84.8300 | -0.80% |
| 2023 | 85.3291 | 77.1800 | 93.4900 | 72.7500 | 85.5100 | 8.72% |
| 2022 | 66.5324 | 54.7000 | 86.1400 | 43.7700 | 78.6500 | 48.28% |
| 2021 | 79.1445 | 119.0700 | 139.4800 | 49.5500 | 53.0400 | -55.33% |
| 2020 | 101.0665 | 115.2700 | 121.8200 | 74.3400 | 118.7500 | 3.35% |
| 2019 | 109.5747 | 97.3000 | 138.5200 | 81.7400 | 114.9000 | 14.84% |
| 2018 | 90.5582 | 63.1000 | 116.6300 | 60.7200 | 100.0500 | 72.26% |
| 2017 | 43.6000 | 39.6000 | 58.9900 | 36.9000 | 58.0800 | 44.48% |
| 2016 | 33.6385 | 31.2500 | 41.0400 | 26.1300 | 40.2000 | 24.69% |
| 2015 | 38.4527 | 36.9200 | 45.3800 | 30.8500 | 32.2400 | -13.84% |
| 2014 | 35.9682 | 41.2800 | 43.3700 | 30.3600 | 37.4200 | -11.18% |
| 2013 | 41.3454 | 42.1300 | 45.8100 | 37.7500 | 42.1300 | 3.16% |
| 2012 | 36.4214 | 31.3900 | 41.3800 | 30.9250 | 40.8400 | 33.42% |
| 2011 | 31.0832 | 30.1400 | 35.1000 | 27.5050 | 30.6100 | -3.10% |
| 2010 | 28.1781 | 27.7150 | 32.1900 | 25.6200 | 31.5900 | 14.56% |
| 2009 | 27.4175 | 28.0050 | 32.3250 | 24.4250 | 27.5750 | -2.39% |
| 2008 | 28.8424 | 30.9200 | 32.7100 | 24.7950 | 28.2500 | -10.35% |
| 2007 | 25.2441 | 22.6900 | 31.5100 | 21.7500 | 31.5100 | 39.98% |
| 2006 | 24.0376 | 24.4000 | 27.4500 | 20.5450 | 22.5100 | -7.86% |
| 2005 | 21.6156 | 18.4000 | 26.3950 | 17.0800 | 24.4300 | 34.94% |
| 2004 | 15.1271 | 11.9700 | 18.4950 | 11.8700 | 18.1050 | 51.57% |
| 2003 | 10.5794 | 11.0000 | 12.2350 | 8.2400 | 11.9450 | 11.32% |
| 2002 | 13.6927 | 16.8400 | 17.1750 | 9.3500 | 10.7300 | -36.73% |
| 2001 | 16.3680 | 14.8450 | 20.8500 | 13.7000 | 16.9600 | 9.84% |
| 2000 | 11.8993 | 11.7800 | 15.4400 | 9.9400 | 15.4400 | 29.69% |
| 1999 | 9.4026 | 11.3450 | 12.0300 | 6.9050 | 11.9050 | 4.66% |
| 1998 | 8.7493 | 7.1550 | 11.4050 | 6.7500 | 11.3750 | 62.50% |
| 1997 | 8.5821 | 9.3750 | 10.3450 | 6.9050 | 7.0000 | -25.85% |
| 1996 | 9.1787 | 8.8750 | 10.5000 | 8.1875 | 9.4400 | 6.37% |
| 1995 | 9.0690 | 8.6900 | 11.5000 | 6.5650 | 8.8750 | 2.13% |
| 1994 | 9.6435 | 13.5000 | 13.6900 | 7.2500 | 8.6900 | -37.37% |
| 1993 | 11.7904 | 12.4700 | 14.1250 | 8.3750 | 13.8750 | 5.96% |
| 1992 | 8.4564 | 9.0950 | 13.0950 | 6.1875 | 13.0950 | 38.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.260B | $1.309B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.157B | 25.91 |
| Stryker (SYK) | United States | $148.171B | 33.39 |
| Boston Scientific (BSX) | United States | $133.131B | 38.28 |
| EssilorLuxottica (ESLOY) | France | $113.461B | 0.00 |
| Medtronic (MDT) | Ireland | $109.010B | 16.19 |
| Haleon (HLN) | United Kingdom | $42.913B | 27.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.122B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.701B | 19.56 |
| ResMed (RMD) | United States | $34.955B | 28.72 |
| Terumo (TRUMY) | Japan | $29.203B | 41.24 |
| Koninklijke Philips (PHG) | Netherlands | $24.410B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.087B | 14.06 |
| Insulet (PODD) | United States | $18.377B | 73.18 |
| Baxter (BAX) | United States | $16.604B | 10.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.153B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.468B | 37.96 |
| Bio-Rad Laboratories (BIO) | United States | $8.977B | 30.51 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.523B | 12.83 |
| TG Therapeutics (TGTX) | United States | $4.720B | 0.00 |
| ICU Medical (ICUI) | United States | $4.155B | 39.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.074B | 20.26 |
| Perrigo (PRGO) | Ireland | $3.716B | 10.94 |
| Envista Holdings (NVST) | United States | $3.487B | 25.97 |
| Neogen (NEOG) | United States | $3.270B | 37.72 |
| Agios Pharmaceuticals (AGIO) | United States | $3.103B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.789B | 17.89 |
| QuidelOrtho (QDEL) | United States | $2.595B | 16.70 |
| Warby Parker (WRBY) | United States | $2.344B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.332B | 56.69 |
| Green Thumb Industries (GTBIF) | United States | $1.964B | 34.37 |
| AtriCure (ATRC) | United States | $1.772B | 0.00 |
| InMode (INMD) | Israel | $1.487B | 8.94 |
| Curaleaf Holdings (CURLF) | Canada | $1.348B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.311B | 9.37 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.168B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.957B | 7.48 |
| CeriBell (CBLL) | United States | $0.916B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.888B | 29.68 |
| Capricor Therapeutics (CAPR) | United States | $0.839B | 0.00 |
| Evolus (EOLS) | United States | $0.785B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.608B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.596B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.596B | 26.47 |
| Surmodics (SRDX) | United States | $0.559B | 0.00 |
| Quanterix (QTRX) | United States | $0.424B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.404B | 0.00 |
| Valneva SE (VALN) | France | $0.370B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.63 |
| Omeros (OMER) | United States | $0.349B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.335B | 31.89 |
| Biote (BTMD) | United States | $0.330B | 7.25 |
| Sanara MedTech (SMTI) | United States | $0.323B | 0.00 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.288B | 19.30 |
| Zynex (ZYXI) | United States | $0.249B | 52.13 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.15 |
| MacroGenics (MGNX) | United States | $0.218B | 0.00 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| Sanuwave Health (SNWV) | United States | $0.195B | 2.74 |
| Jin Medical (ZJYL) | China | $0.188B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.162B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 96.70 |
| Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.98 |
| TriSalus Life Sciences (TLSI) | United States | $0.126B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 10.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.00 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.082B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.080B | 41.50 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.066B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| Exagen (XGN) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.026B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.17 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |